“I have yet another study on my desk showing the benefits of Chromium,” says Dr Jonathan Wright of
Nutrition & Healing.
“This time researchers used electrocardiograms to measure the heart function in patients with
type II diabetes who supplemented with chromium. What they found was that a specific measurement on the test showed clear improvement after chromium supplementation, indicating a reduction in
heart disease risk,” says Dr Wright.
“Scientists found that the duration of ventricular contraction of the heart muscle in those who took 1 milligram of chromium picolinate per day was significantly shorter than in those given a placebo,” explains Dr Wright.
For type II diabetics, insulin resistance means an increased risk of
heart disease.
But the good news for
type II diabetes sufferers is that “since chromium acts to boost insulin’s effect, it potentially reduces insulin resistance and the subsequent risk of heart disease,” says Dr Wright.
-------------------------------------------------------------------------------------------------
Daily insulin injections are a distant memory for Catherine Downs now...
In fact, the 56-year old diabetic has almost forgotten she ever had full-blown type II diabetes.
No more syringes. She's even lowered her hypoglycaemic prescription to only 2mg per day. And get this… She's eating like a normal person again, sugary sweets and all.
How did she do it? She found out about an unknown sugar-buster hiding in a most unlikely place...
Find out what it is here...
-------------------------------------------------------------------------------------------------
The benefits of chromium for people with type II diabetes
The study involved fifty people with type II diabetes who were managing their disease through diet alone. Those in the trial had no evidence of serious complications such as heart or kidney failure.
They were randomly assigned to either receive the chromium or a placebo for three months. After the three month period, the two groups switched and each received the other’s treatment for another three months.
“At the end of the first three months, insulin levels were significantly lower in the chromium group than in the placebo group. Their insulin levels stayed down during the second three months of the study when the individuals were only given a placebo, suggesting the effects of chromium supplementation persisted even after treatment had stopped. The group that received chromium during the second three months of the study experienced a similar drop in insulin levels by the end of the study,” says Dr Wright.
Although the news on chromium continues to be good, “always check with your doctor when considering adding a particular supplement. Decide together what would be right for you,” advises Dr Wright.
Home
Search
Menu
Our products
Who we are
